Newsroom

Sorted by: Latest

-

Kriya Selected for FDA PreCheck Pilot Program

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kriya Therapeutics Selected for FDA PreCheck Pilot Program...
-

Esri贊助史密森學會展覽,展示全美50個州的自然與文化瑰寶

加州雷德蘭茲--(BUSINESS WIRE)--(美國商業資訊)-- 位置智慧領域的全球領導者Esri正在贊助史密森學會國家自然歷史博物館的全新展覽——「來自這片土地:分享我們的自然與文化資產」(From These Lands: Sharing Our Natural and Cultural Heritage)。該展覽展示了來自全美50個州的珍貴展品,深入探討了將美國密切相連的人、地域與自然世界之間的深厚紐帶。 該展覽於今年6月18日開幕,將持續展出至2029年。展覽聚集來自全美各地、華盛頓特區以及五個美國海外領地的600多件標本和文化文物。憑藉博物館自身的豐富館藏,「來自這片土地」生動展現了自然系統、文化傳統與地理環境如何交織融合。 展覽呈現了跨越數百萬年的故事——從遠古化石、地質構造到文化文物與科學突破,邀請參觀者重新審視自己與所處地域的情感連結。透過將自然標本與文化物品並置展示,「來自這片土地」深刻揭示了人類文化既受自然世界塑造,又反過來正向影響自然世界的雙重關係。 Esri的技術在詮釋這些主題的過程中發揮了核心作用。展廳內的動畫地圖讓參觀者能夠透過地形、生物群落、地質構造...
-

Herbalife Outlines 3.5-Hour Pre-Match Fueling Window in “Fuel Like Ronaldo” Campaign

LOS ANGELES--(BUSINESS WIRE)--Herbalife, a premier health and wellness company, community and platform, is expanding its global “Fuel Like Ronaldo” campaign with a structured 3.5-hour pre-match fueling protocol designed to help athletes build glycogen stores, maintain hydration and protect performance through the final whistle. According to Herbalife’s sports performance experts, what athletes eat and drink in the hours leading up to a match directly shapes how they perform on the field. Nutrit...
-

Samsung Bioepis宣布其Keytruda (Pembrolizumab)候选生物类似药SB27的积极1期和3期初步研究数据

韩国仁川--(BUSINESS WIRE)--(美国商业资讯)-- Samsung Bioepis Co., Ltd.今日宣布,其Keytruda1 (pembrolizumab)候选生物类似药SB27的1期和3期研究均已达到主要终点。 Samsung Bioepis执行副总裁兼临床科学部负责人Donghoon Shin表示:“我们很高兴地宣布pembrolizumab候选生物类似药SB27 1期和3期研究的初步结果。这些积极的顶线结果巩固了我们在生物类似药开发领域的科学专业能力和领导地位。我们正稳步推进在今年内完成1期和3期研究的计划。依托我们强大的质量管理体系,我们持续致力于推进本公司的生物类似药产品组合,以扩大存在未满足医疗需求的患者获得救命生物药的途径。” Pembrolizumab是一种人源化单克隆抗体,通过靶向并阻断T细胞上的程序性死亡蛋白1 (PD-1)受体来发挥免疫检查点抑制剂的作用。它被用于治疗多种癌症,包括黑色素瘤、非小细胞肺癌(NSCLC)和头颈部鳞状细胞癌(HNSCC)。2 这项随机、双盲、三臂、平行组、多中心的1期临床试验证明了SB27 (pembrolizu...
-

Lemonade Expands Renters Insurance to Mississippi

NEW YORK--(BUSINESS WIRE)--Lemonade (NYSE: LMND), the tech-first insurance company, today announced the availability of its renters insurance in Mississippi. The expansion gives renters across the state a simple, fast way to get coverage that fits their lifestyles. Lemonade Renters provides flexible coverage options via an app where renters can get quotes, purchase policies, update existing policies, and file claims, all in one place. About 40% of claims are handled instantly, helping renters r...
-

Esri sponsert Smithsonian-Ausstellung mit Natur- und Kulturgütern aus allen 50 Bundesstaaten

REDLANDS, Kalifornien--(BUSINESS WIRE)--Esri, der Weltmarktführer im Bereich Location Intelligence, ist Sponsor der neuen Ausstellung From These Lands: Sharing Our Natural and Cultural Heritage im National Museum of Natural History des Smithsonian, die Exponate aus allen 50 Bundesstaaten präsentiert und die tiefen Verbindungen zwischen Menschen, Orten und der Natur beleuchtet, die die Nation vereinen. Die Ausstellung, die am 18. Juni dieses Jahres eröffnet wurde und bis 2029 läuft, umfasst mehr...
-

Esri patrocina exposição da Smithsonian que apresenta objetos naturais e culturais de todos os 50 estados

REDLANDS, Califórnia--(BUSINESS WIRE)--Esri, líder mundial em inteligência de localização, está patrocinando Destas Terras: Compartilhando Nosso Patrimônio Natural e Cultural, uma nova exposição no Museu Nacional de História Natural da Smithsonian que apresenta objetos de todos os 50 estados e explora as profundas conexões entre pessoas, lugares e o mundo natural que unem a nação. A exposição, inaugurada em 18 de junho e estando aberta até 2029, reúne mais de 600 espécimes e objetos culturais d...
-

Riassunto: Samsung Bioepis annuncia dati preliminari positivi provenienti da trial di fase 1 e fase 3 per SB27, una proposta di farmaco biosimilare di Keytruda (pembrolizumab)

INCHEON, Corea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. ha annunciato oggi che gli studi di fase 1 e fase 3 condotti su SB27, una proposta di biosimilare di Keytruda (pembrolizumab), hanno incontrato i rispettivi endpoint primari. “Siamo entusiasti di annunciare i risultati preliminari degli studi di fase 1 e fase 3 per SB27, il nostro candidato biosimilare di pembrolizumab. Questi importanti risultati positivi rafforzano la nostra competenza ed eccellenza scientifica nello sviluppo di farma...
-

Sultan Bin Ahmed bierze udział w uroczystości rozdania dyplomów ukończenia studiów drugiego stopnia w Hiszpanii

BARCELONA, Hiszpania--(BUSINESS WIRE)--W ubiegły piątek Jego Wysokość Szejk Sultan bin Ahmed bin Sultan al-Kasimi, zastępca emira Szardży i rektor Uniwersytetu w Szardży (UOS), pojawił się na Uniwersytecie Barcelońskim, aby wziąć udział w uroczystości rozdania dyplomów ukończenia studiów drugiego stopnia pierwszym absolwentom studiów magisterskich w dziedzinie przedsiębiorczości w mediach i cyfrowych innowacji – unikalnego kierunku oferowanego przez Uniwersytet Barceloński we współpracy z Wydzi...
-

Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Inspire Medical Systems, Inc. (NYSE: INSP). In August of 2025, contrary to the Company’s repeated assurances that it had met all regulatory, technical, and commercial prerequisites for the launch of its Inspire V device, the Company disclosed that the launch faced an "elonga...